1. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. Issue 10 (October 2022) Authors: Tree, Alison C; Ostler, Peter; van der Voet, Hans; Chu, William; Loblaw, Andrew; Ford, Daniel; Tolan, Shaun; Jain, Suneil; Martin, Alexander; Staffurth, John; Armstrong, John; Camilleri, Philip; Kancherla, Kiran; Frew, John; Chan, Andrew; Dayes, Ian S; Duffton, Aileen; Brand, Douglas H; Henderson... Journal: Lancet oncology Issue: Volume 23:Issue 10(2022) Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗